List view / Grid view
In this article, Steffanie Wilson, Vice President and Neuroscience Therapeutic Area Lead, Emmes Group, discusses the future of psychedelic research and highlights the impact of the FDA’s decision on Lykos Therapeutics’ NDA for its MDMA therapy to treat PTSD.
The largest clinical trial of its kind will investigate if ketamine-assisted therapy can reduce harmful drinking in people with severe alcohol use disorder.
The Canadian Government is funding studies to establish ketamine as a safe and effective treatment for patients with bipolar depression.
NICE has said commonly used treatments for chronic primary pain such as paracetamol have little or no evidence that they work and should not be prescribed for the condition.
Ketamine may be a favourable option in comparison to an opioid, especially for patients with opioid use disorders, or substance use disorders...
Ketamine, a medication commonly used for pain relief and increasingly used for depression, may help alleviate migraine pain...
